Compare ABCL & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | BLND |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 894.7M |
| IPO Year | 2020 | 2021 |
| Metric | ABCL | BLND |
|---|---|---|
| Price | $3.65 | $3.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $7.75 | $4.80 |
| AVG Volume (30 Days) | 3.7M | ★ 4.0M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $35,325,000.00 | ★ $167,532,000.00 |
| Revenue This Year | $25.45 | N/A |
| Revenue Next Year | $10.07 | $19.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.17 | ★ 37.61 |
| 52 Week Low | $1.89 | $2.50 |
| 52 Week High | $6.52 | $5.34 |
| Indicator | ABCL | BLND |
|---|---|---|
| Relative Strength Index (RSI) | 41.40 | 49.24 |
| Support Level | $3.51 | $3.18 |
| Resistance Level | $3.84 | $3.40 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 55.68 | 48.89 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.